IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation

Journal of Clinical Investigation

Volumn 115, Issue 3, 2005, Pages 747-754

  Vladich, Frank D ^a   Brazille, Susan M ^a   Stern, Debra ^a   Peck, Michael L ^a   Ghittoni, Raffaella ^a,c   Vercelli, Donata ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD23 ANTIGEN; GLUTAMINE; HYDROCORTISONE; IMMUNOGLOBULIN E; INTERLEUKIN 13; STAT6 PROTEIN;

ALLERGIC ASTHMA; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL;

ANIMALS; ASTHMA; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-13; MONOCYTES; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGE; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 14644435711     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200522818     Document Type: Article

References (69)

1. Cohn, L., Elias, J.A., and Chupp, G.L. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789-815.
2. Walter, D.M., et al. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167:4668-4675.
3. Wills-Karp, M., et al. 1998. Interleukin-13: Central mediator of allergic asthma. Science. 282:2258-2261.
4. Grünig, G., et al. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:2261-2263.
5. Zhu, Z., et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788.
6. Lee, C., et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β-1. J. Exp. Med. 194:809-821.
7. Lanone, S., et al. 2002. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110:463-474. doi:10.1172/JCI200214136.
8. Lee, J.H., et al. 2001. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Cell. Mol. Biol. 25:474-485.
9. Zhu, Z., et al. 2004. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science. 304:1678-1682.
10. Mattes, J., et al. 2002. Intrinsic defect in T cell production of IL-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433-1444.
11. Shinkai, K., Mohrs, M., and Locksley, R.M. 2002. Helper T cells regulate type-2 innate immunity in vivo. Nature. 420:825-829.
12. Yang, M., et al. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy Clin. Immunol. 112:935-943.
13. Voehringer, D., Shinkai, K., and Locksley, R.M. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 20:267-277.
14. Punnonen, J., et al. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U. S. A. 90:3730-3734.
15. Cosentino, G., et al. 1995. IL-13 downregulates CD14 expression and TNF-α secretion in human monocytes. J. Immunol. 155:3145-3151.
16. Gould, H.J., et al. 2003. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21:579-628.
17. Williams, T.J., Jones, C.A., Miles, E.A., Warner, J.O., and Warner, J.A. 2000. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J. Allergy Clin. Immunol. 105:951-959.
18. Ribeiro-do-Couto, L.M., et al. 2001. High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur. J. Immunol. 31:3394-3402.
19. Martinez, F.D. 2003. Toward asthma prevention-does all chat really matters happen before we learn to read? N. Engl. J. Med. 349:1473-1475.
20. Cookson, W.O., and Moffatt, M.F. 2000. Generics of asthma and allergic disease. Hum. Mol. Genet. 9:2359-2364.
21. Vercelli, D. 2003. Genetic polymorphism in allergy and asthma. Curr. Opin. Immunol. 15:609-613.
22. Graves, P.E., et al. 2000. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J. Allergy Clin. Immunol. 105:506-513.
23. Liu, X., et al. 2000. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J. Allergy Clin. Immunol. 106:167-170.
24. Wang, M., et al. 2003. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum. Genet. 113:387-390.
25. Heinzmann, A., et al. 2003. Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis. J. Allergy Clin. Immunol. 112:735-739.
26. Heinzmann, A., et al. 2000. Genetic variants of IL-13 signalling and human asthma and atopy. Hum. Mol. Genet. 9:549-559.
27. He, J.Q., et al. 2003. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 4:385-389.
28. Tsunemi, Y., et al. 2002. Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J. Dermatol. Sci. 30:100-107.
29. DeMeo, D., et al. 2002. Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet. Epidemiol. 23:335-348.
30. van der Pouw Kraan, T.C., et al. 1999. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1:61-65.
31. Howard, T.D., et al. 2001. Identification and association of polymorphisms in the Interleukin-13 gene with asthma and atopy in a Dutch population. Am. J. Respir. Cell. Mol. Biol. 25:377-384.
32. Liu, X., et al. 2003. Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J. Allergy Clin. Immunol. 112:382-388.
33. Hummelshoj, T., et al. 2003. Association between an interleukin-13 promoter polymorphism and atopy. Eur. J. Immunogenet. 30:355-359.
34. Howard, T.D., et al. 2002. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J. Hum. Genet. 70:230-236.
35. Hoffjan, S., Nicolae, D., and Ober, C. 2003. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir. Res. [serial online]. 4:14. http://respiratory-research.com.
36. Daly, M.J., Rioux, J.D., Schaffner, S.F., Hudson, T.J., and Lander, E.S. 2001. High-resolution haplotype structure in the human genome. Nat. Genet. 29:229-232.
37. Arima, K., et al. 2002. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J. Allergy Clin. Immunol. 109:980-987.
38. Chen, W., Ericksen, M.B., Levin, L.S., and Khurana Hershey, G.K. 2004. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J. Allergy Clin. Immunol. 114:553-560.
39. Madhankumar, A.B., Mintz, A., and Debinski, W. 2002. Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine. J. Biol. Chem. 277:43194-43205.
40. Minty, A., et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:248-250.
41. Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T., and Akira, S. 1996. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157:3220-3222.
42. Brown, H., and Prescott, R. 1999. Applied mixed models in medicine. John Wiley & Sons Ltd. Chichester, United Kingdom/New York, New York, USA. 442 pp.
43. Vercelli, D., et al. 1988. Human recombinant interleukin 4 induces FcεR2/CD23 on notmal human monocytes. J. Exp. Med. 167:1406-1416.
44. Köhler, I., and Rieber, E.P. 1993. Allergy-associated Iε and Fcε receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 23:3066-3071.
45. Vercelli, D. 2001. IgE and its regulators. Curr. Opin. Allergy Clin. Immunol. 1:61-65.
46. Jabara, H.H., Brodeur, S.R., and Geha, R.S. 2001. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107:371-378.
47. Hershey, G.K. 2003. IL-13 receptors and signaling pathways: an evolving web [review]. J. Allergy Clin. Immunol. 111:677-690.
48. Kioi, M., Kawakami, K., and Puri, R.K. 2004. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R. Cell. Immunol. 229:41-51.
49. Eisenmesser, E.Z., Horita, D.A., Altieri, A.S., and Byrd, R.A. 2001. Solution structure of interleukin-13 and insights into receptor engagement. J. Mol. Biol. 310:231-241.
50. Carlson, C.S., Eberle, M.A., Kruglyak, L., and Nickerson, D.A. 2004. Mapping complex disease loci in whole-genome association studies. Nature. 429:446-452.
51. Botstein, D., and Risch, N. 2003. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease [review]. Nat. Genet. 33(Suppl.):228-237.
52. Donaldson, D.D., et al. 1998. The murine IL-13 receptor α2: Molecular cloning, characterization and comparison with murine IL-13 receptor α1. J. Immunol. 161:2317-2324.
53. Wood, N., et al. 2003. Enhanced Interleukin-13 responses in mice lacking IL-13 receptor α2. J. Exp. Med. 197:703-709.
54. Zheng, T., et al. 2003. Cytokine regulation of IL-13Rα2 and IL-13Rα1 in vivo and in vitro. J. Allergy Clin. Immunol. 111:720-728.
55. Oshima, Y., Joshi, B.H., and Puri, R.K. 2000. Conversion of interleukin-13 into a high affinity agonise by a single amino acid substitution. J. Biol. Chem. 275:14375-14380.
56. LeVan, T.D., et al. 2001. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167:5838-5844.
57. Schweiger, A., et al. 2001. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3. J. Allergy Clin. Immunol. 107:505-510.
58. Tokuhiro, S., et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-348.
59. Silverman, E.S., et al. 2004. Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169:214-219.
60. Ozaki, K., et al. 2004. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature. 429:72-75.
61. Knight, J.C., Keating, B.J., and Kwiatkowski, D.P. 2004. Allele-specific repression of lymphotoxin-α by activated B cell factor-1. Nat. Genet. 36:394-399.
62. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S., and Hirschhorn, J.N. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33:177-182.
63. Tepper, R.I., et al. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 62:457-467.
64. Dent, L.A., Strath, M., Mellor, A.L., and Sandetson, C.J. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172:1425-1431.
65. Jabara, H.H., Ahern, D.J., Vercelli, D., and Geha, R.S. 1991. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147:1557-1560.
66. Moy, F.J., Diblasio, E., Wilhelm, J., and Powers, R. 2001. Solution structure of human IL-13 and implication for receptor binding. J. Mol. Biol. 310:219-230.
67. Monticelli, S., Ghittoni, R., Kabesch, M., and Vercelli, D. 2002. Myb proteins repress human ε germline transcription by inhibiting STAT6-dependent promoter activation. Mol. Immunol. 38:1129-1138.
68. Albesiano, E., et al. 2003. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood. 102:3333-3339.
69. Jabara, H.H., Fu, S.M., Geha, R.S., and Vercelli, D. 1990. CD40 and IgE: Synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861-1864.